Skip to content

MENU

Cristelle Santos - Broughton - Consultant Toxicologist

Downloadable Resources

Ensuring-Safety-in-the-Booming-CBD-Industry:-A-Proposed-Safety-Framework

Ensuring Safety in the Booming CBD Industry: A Proposed Safety Framework

The rapid growth of the cannabis market has outpaced the establishment of comprehensive safety standards and regulations. To help create a pathway towards safe, secure, and reliably-regulated CBD products, Cristelle Santos, Consultant Toxicologist at Broughton, has proposed a safety framework.

Click to download

Broughton:-Your-Medical-Cannabis-Compliance-and-Market-Entry-Partner

Broughton: Your Medical Cannabis Compliance and Market Entry Partner

As the medical cannabis market grows, expertise in testing, regulatory compliance, and quality control play a pivotal role in assisting category innovators in bringing their products to market.

Click to download

Cannabis-Services

Cannabis Services

Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services. 

Click to download

Toxicology-Advice-and-Consultancy-Services

Toxicology Advice and Consultancy Services

Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.

Click to download

Whitepaper:-A-Summary-of-the-Legal-Status-and-Regulatory-Pathways-to-Market-for-Cannabinoid-Products-in-the-UK-Market

Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market

Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route. 

Click to download

Whitepaper:-Review-of-the-degradation-pathways-of-cannabinoids,-the-potential-impact-on-medicinal-and-consumer-products,-and-discussion-of-mitigation-solutions-

Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions

In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD). 

Click to download

Whitepaper:-Does-CBD-Really-Harm-the-Liver?

Whitepaper: Does CBD Really Harm the Liver?

Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.

Click to download

Whitepaper:-Why-Cannabinoid-analytical-methodologies-are-the-foundations-of-building-a-mainstream-cannabis-industry

Whitepaper: Why Cannabinoid analytical methodologies are the foundations of building a mainstream cannabis industry

In this whitepaper, we discuss the range of validated analytical methods required to support the comprehensive characterization of various dosage forms of cannabinoid products. 

Click to download